Saturday, February 21, 2015

Stem Cells in Ophthalmology Update 24: Current Tables Now Online

My current stem cell/cell therapy tables are now online for anyone interested to access. Here is a brief description of what is available and how to access them:

Stem Cell/Cell Therapy Companies/Institutions Active in Ophthalmology

A list of forty-one companies and institutions working with stem cells/cell therapies for ophthalmic applications. The table lists collaborators, the cell type being used, and the applications for which the cells will be used.


Stem Cell/Cell Therapy in Ophthalmology by Application

A list of eighteen ophthalmic applications being studied and/or in clinical trials. The table includes the companies/institutions involved, the clinical trial status, and an active link for the clinical trial for those listed. (Fifty-three active and completed clinical trials are shown.)


Stem Cell/Cell Therapy in Ophthalmology -- Ongoing & Completed Clinical Trial Details

A list of the the eighteen ophthalmic applications and the fifty-three clinical trials showing the number of patients to be studied in each trial and the number studied to date (that I am aware of). Active links are provided for each ongoing or completed trial.

Link: http://tinyurl.com/StemCellClncl429


Updated April 29, 2015. 

10 Comments:

At 5:18 PM, Blogger Luca said...

Ciao Irv,

What great resources. Thank you for sharing.

You should also make your posts sharable via social media. I'd like to send these to my ophthalmic network.

Luca

 
At 6:17 PM, Blogger Irv Arons said...

Luca,

Sign up for my Twitter account in the right margin. I always announce new postings on Twitter

 
At 2:07 PM, Blogger Sandro Pretolani said...

Irv,thank you for your invaluable work - however I have a lot of problems to find RESULTS of clinical trials...I think it is of little usefulness to know of clinical trials without be updated by sponsors about results

 
At 3:48 PM, Blogger Irv Arons said...

Sandro, I agree. Unfortunately, the companies sponsoring the trials keep the results close to the vest until they can get them published in a peer-reviewed publication.

Only dribs and drabs of the results sometimes come out as part of presentations by the doctors who are involved in the trials.

 
At 2:42 PM, Blogger Sandro Pretolani said...

I really agree about the rights of who has spent his money about research details ,but I think it is immoral to continue to maintain hopes on clinical trials ended several years ago, with no publications of any kind - it is quite likely that these results have been negative, but I think we should require sponsors to publish at least the most important data: positive, negative ,so-and-so - obviously IMO

 
At 10:22 AM, Blogger loch said...

these tables are amazing. could you add a column for 'target cell type'? e.g. - RPE cell, photoreceptor, gimbal cell? this info is sometimes in the application column, but not always and it is mixed with other stuff there.

 
At 12:03 PM, Blogger Irv Arons said...

Loch,

I don't know the "target cell" in all cases, that's why it was not included in the table. In some cases, like RPE-derived from hESCs, it is obvious.

I also have a blog entry aimed at rejuvenating photoreceptor cells -- see: A New Approach for Repairing/Rejuvenating Damaged Photoreceptors http://tinyurl.com/RetProgenCells for those with RP and other retinal diseases.
(A condensed version was just published in The Opthalmologist: Regenerating the Retina using retinal progenitor cells, who’s involved. Rejuvenating photoreceptors - rods & cones. https://theophthalmologist.com/issues/0215/regenerating-the-retina/)

 
At 12:44 PM, Blogger loch said...

thanks. any chance you could send me a excel or CSV version of table 1?

 
At 12:50 PM, Blogger Irv Arons said...

Loch,

I only have the table in Word Perfect (my preferred word processor),but can convert to Word, or as a PDF.

And, I need your email address. Mine is iarons(at)erols.com

 
At 10:58 AM, Anonymous Andy blidy said...

Irv, thanks for the updates of all Ocata trials

 

Post a Comment

<< Home